Preparation of ![]() |
Hong, Jun-Pyo
(Department of Medical Laboratory Science, College of Health Science, Yonsei University)
Awh, Ok-Doo (Department of Medical Laboratory Science, College of Health Science, Yonsei University) Kim, Hyun-Suk (Department of Medical Laboratory Science, College of Health Science, Yonsei University) Lee, Eun-Sook (Department of Medical Laboratory Science, College of Health Science, Yonsei University) Lee, Tae-Sup (Department of Medical Laboratory Science, College of Health Science, Yonsei University) Choi, Tae-Hyun (Department of Medical Laboratory Science, College of Health Science, Yonsei University) Choi, Chang-Woon (Department of Nuclear Medicin, Yonsei University) Lim, Sang-Moo (Department of Nuclear Medicin, Yonsei University) |
1 | Babich JW, Tompkins RG, Graham W, BarrowSA, Fischman AJ. Localization of radiolabeledchemotactic peptide at focal sites of Escherichiacoli infection in rabbits: evidence for areceptor-specific mechanism. J Nucl Med 1997;38(8):1316-22. |
2 | Rennen HJ, Boerman OC, Oyen WJ. CorstensFR. Imaging infection/inflammation in the newmillennium. Eur J Nucl Med. 2001;28(2):241-52. |
3 | Woodle MC, Lasic DD. Sterically stabilizedliposomes. Biochi Biophy Acta. 1992; 1113(2):171-99. |
4 | Woodle MC, Matthay KK, Newman MS,Hidayat JE, Collins LR, Redemann C, et alVersatility in lipid compositions showingprolonged circulation with sterically stabilizedliposomes. Biochi Biophy Acta. 1992;1105(2):193-200. |
5 | Liu S, Edwards DS, Barrett JA. 99mTc labelingof highly potent small peptides. Bioconj Chern1997;8(5):621-36. |
6 | Jones GS, Elmaleh Jr DR, Strauss HW,Fischman AJ. 7,10-bis (2-mercapto-2-methyl)propyl-7,10-diazapalmitic acid: a novel, N2S2ligand for technetium-99m. Bioorg Med Chem1996 Lett. 6(20):2399-404. |
7 | Goins BA, Phillips WT. The use of scintigraphicimaging as a tool in the development of liposomesformulations. Prog Lipid Res 2001;40:95-123. |
8 | Oku N, Namba Y, Takeda A, Okada S. Tumorimaging with technetium-99m-DTP A encapsulatedin RES-avoiding liposomes. Nucl Med Bioi1993;20(4):407-12. |
9 | Gabizon AA. Selective tumor localization andimproved therapeutic index of anthra¢yclinesencapsulated in long-circulating liposomes.Cancer Res 1992;52(4):891-6. |
10 | Allen TM, Hansen C, Rutledge J. liposomeswith prolonged circulation times: factorsaffecting uptake by reticuloendothelial and othertissues. Biochi Biophy Acta 1989;981(1):27-35. |
11 | Russell CD, Speiser AG. Complexes oftechnetium with hydroxy carboxylic acids:gluconic, glucoheptonic, tartaric, and citric. JNucl Med 1980;21(11):1086-90. |
12 | Enoch HG, Strittmatter P. Formation andproperties of 1000-A-diameter, singlebilayerphospholipid vesicles. Proc Natl AcM Sci1979;76(1): 145-9. |
13 |
Edwards DS, Liu S, Barrett JA, Harris AR,Looby RJ, Ziegler MC., et al. New and versatileternary ligand system for technetium radiopharmaceuticals:water soluble phosphines andtricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIareceptor antagonist with |
14 | Laverman P, Dams ET, Oyen WJ, Storm G,Koenders EB, Prevost R, et al A novel methodto label liposomes with 991llTc by the hydrazinonicotinyl derivative. J Nucl Med 1999;40(1):192-7. |
15 | Kubota R, Yamada S, Ishiwata K, Tada M, IdoT, Kubota K. Cellular accumulation of 18F_labelled boronophenyl alanine depending onDNA synthesis and melanin incorporation: adouble-tracer microautoradiographic study ofB16 melanomas in vivo. Br J Cancer 1993;67(4):701-5. |
16 | Milind Rajopadhye D, Scott Edwards Jeffrey P,Bourque, Timothy R. Carroll, Synthesis andtechnetum-99M labeling of cyclic GP IIB/IlIAreceptor antagonists conjugated to 4,5-bis (mercaptoacetamido)-pentanoic acid (MAPT). BioorgMed Chem Lett. 1996;6(15):1737-40. |
17 | Babich JW, Graham W, Barrow SA, DragotakesSC, Tompkins RG, Rubin RH, et al. Technetium-99m-Iabeled chemotactic peptides: comparisonwith indium-Ill-labeled white bloodcells for localizing acute bacterial infection in the rabbit. J Nucl Med 1993;34(12):2176-81. |
18 | Boerman OC, Oyen WJ, van Bloois L,Koenders EB, van der Meer JW, Corstens FH,et al. Optimization of technetium-99m-labeledPEG liposomes to image focal infection: effectsof particle size and circulation time, J Nucl Med1997 ;38(3) :489-93. |
19 | Bakker-Woudenberg lA, Lokerse AF, tn KateMT, Mouton JW, Woodle MC, St(jlrm G.liposomes with prolonged blood circulatlion andselective localization in Klebsiella pneumoniaeinfectedlung tissue. J Infect Dis 1993; 168(1):164-71. |
20 | Oyen WJ, Boerman OC, Storm G, van Bloois L,Koenders EB, Crommelin DJ, et al LabelledStealth liposomes in experimental infection: analternative to leukocyte scintigraphy? Nucl Med Cornrnun. 1996;17(9):742-8. |
21 | Abrams MJ, Juweid M. tenKate CI., SchwartzDA, Hauser MM., Gaul FE, et al. Technbtium-99m-human polyclonal IgG radiolabeled via thehydrazino nicotinamide derivative for imagingfocal sites of infection in rats. J Nucl Med1990;31(12):2022-8. |
22 | Awasthi V, Goins B, Klipper R, Loredo R,Korvick D, Phillips WT. Imaging experimentalosteomyelitis using radiolabeled Iiposomes. JNucl Med 1998;39(6):1089-94. |
23 | van der Lake CJ, Boerman OC, Oyen WJ, vande ven MT, Edwards DS. Technetium-99mlabeledchemotactic peptides in acute infectionand sterile inflammation. J Nucl Med. 1997;38(8):1310-5. |
24 | King TP, Zhao SW, Lam T. Preparation ofprotein conjugates via intermolecular hydrazonelinkage. Biochemistry 1986;25(19):5774-9. |
25 | Goins B, Phillips WT, Klipper R. Bl0od-poolimaging using technetium-99m-labeled liposomesoJ Nucl Med 1996;37(8):1374-9. |
26 | Boerman OC, Oyen WJ, Storm G, Corvo ML,van Bloois L, van der Meer JW., et alTechnetium-99m-Iabeled liposomes to imageexperimental colitis in rabbits: comparison withtechnetium-99m-HMP AO-granulocytes and technetium-99m-HYNIC-IgG, J Nucl Med. 1997;39(12):2172-8. |
27 | Jeong JM, Kinuya S, Paik CH, Saga T, SoodVK, Carrasquillo JA, Neumann RD., et al.Application of high affinity binding concept toradiolabel avidin with Tc-99m labeled biotin andthe effect of pI on biodistribution. Nucl Med Bioi 1994;21(7):935-40. |
28 | Treat J, Greenspan A, Forst D, Sanchez JA,Ferrans VJ, Potkul LA, et al. Antitumor activityof liposomes-encapsulated doxorubicin in advancedbreast cancer: phase II study. J Nat Cancer [nst1990;82(21): 1706-10. |
![]() |